INCREASED STRIATAL DOPAMINE EFFLUX IN-VIVO FOLLOWING INHIBITION OF CEREBRAL NITRIC-OXIDE SYNTHASE BY THE NOVEL MONOSODIUM SALT OF 7-NITRO INDAZOLE

Citation
Mt. Silva et al., INCREASED STRIATAL DOPAMINE EFFLUX IN-VIVO FOLLOWING INHIBITION OF CEREBRAL NITRIC-OXIDE SYNTHASE BY THE NOVEL MONOSODIUM SALT OF 7-NITRO INDAZOLE, British Journal of Pharmacology, 114(2), 1995, pp. 257-258
Citations number
8
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
00071188
Volume
114
Issue
2
Year of publication
1995
Pages
257 - 258
Database
ISI
SICI code
0007-1188(1995)114:2<257:ISDEIF>2.0.ZU;2-M
Abstract
The role of nitric oxide (NO) in striatal dopamine release has been co ntroversial. Most NO synthase inhibitors affect more than one isoform of the enzyme and exert vasoconstrictor effects which may also affect striatal dopamine function. We now report on the effect of a soluble m onosodium salt of the selective brain NO synthase inhibitor 7-nitro in dazole (7-NINA). Using 7-NINA the first study of selective inhibition of the brain isoform of NO synthase on dopamine efflux in rat striatum was undertaken by use of in vivo microdialysis. Perfusion with 7-NINA (1 mM) increased striatal dopamine efflux. The effect of 7-NINA was p artially antagonized (67%) by co-perfusion with L-arginine (1 mM), the precursor of NO formation in vivo. This suggests that 7-NINA induces a competitive inhibition of NO synthase activity. These data show that endogenous NO has an inhibitory effect on striatal dopamine efflux in vivo.